Effect of TYB-2285 on antigen-induced airway responses in sheep

Pulmonary Pharmacology

Volumn 9, Issue 1, 1996, Pages 49-58

  Abraham, W M ^a   Ahmed, A ^a   Cortes, A ^a   Sielczak, M ^a   Wantanabe, A ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b TOYOBO CO LTD   (Japan)

Author keywords

Airway hyperresponsiveness; Animal model; Asthma; Bronchoconstriction

Indexed keywords

ACETYLCHOLINE; ACREOZAST; ANTIALLERGIC AGENT; ANTIASTHMATIC AGENT; ANTIGEN; ANTIINFLAMMATORY AGENT; CARBACHOL; HISTAMINE; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASCARIS SUUM; ASTHMA; BRONCHOSPASM; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; LUNG LAVAGE; LUNG RESISTANCE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHEEP; SMOOTH MUSCLE CONTRACTION; TRACHEA MUSCLE;

EID: 0030087842     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1996.0006     Document Type: Article

References (32)

1. 1. O'Byrne P M, Dolovich J, Hargreave F E. State of Art: Late asthmatic responses. Am Rev Respir Dis 1987; 136: 740-751.
2. 2. Abraham W M, Baugh L E. Animal models of asthma. In: Busse W W, Holgate S T, eds. Asthma and Rhinitis. Boston, MA: Blackwell Scientific Publications, 1995: 961-977.
3. 3. Cartier A, Thomson N C, Frith P A, Roberts R, Hargreave F E. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982; 70: 170-177.
4. 4. Cockroft D W, Murdock K Y. Changes in bronchial responsiveness to histamine at intervals after allergen challenge. Thorax 1987; 42: 302.
5. 5. Abraham W M, Stevenson J S, Eldridge M, Garrido R, Nieves L. Nedocromil sodium in allergen-induced bronchial responses and airway hyperresponsiveness in allergic sheep. J Appl Physiol 1988; 65: 1062-1068.
6. 6. Wasserman S I, Furukawa C T, Henochowicz S I, Marcoux J P, Prenner B M, Findlay S R, Gross G N, Hudson L D, Myers D J, Steinberg P. Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol. J Allergy Clin Immunol 1995; 95: 541-547.
7. 7. Creticos P, Burk J, Smith E, Comp R, Norman P, Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol 1995; 95: 829-836.
8. 8. Tominaga T, Watanabe A, Hayashi H, Yanagihara Y, Koda A. Effect of TYB-2285 on histamine release from human basophils in the presence/absence of IL-3. Gen Pharmacol 1993; 24: 345-348.
9. 9. Watanabe A, Tominaga T, Hayashi H, Yanagihara Y, Koda A. Effect of TYB-2285 on antigen-induced histamine release from mouse bone marrow-derived persisting cells (P-cells) primed with interleukin-3-containing conditioned medium (IL3-CM). Gen Pharmacol 1993; 24: 1207-1211.
10. 10. Muraki M, Tohda Y, Sugihara R, Nagasaka Y, Nakajima S. The effect of TYB-2285 on dual phase bronchoconstriction and airway hypersensitivity in guinea-pigs actively sensitized with ovalbumin. J Pharm Pharmacol 1993; 46: 883-886.
11. 11. Tominaga T, Watanabe A, Noma S, Tsuji J, Koda A. The effects of TYB-2285 and its metabolites on eosinophil adherence to tumor necrosis factor α (TNF-α)-stimulated human umbilical vein endothelial cells. Allergology International 1996; Abstract.
12. 12. Tominaga T, Watanabe A, Tsuji J, Koda A, Nagai H, Kumazawa Y, Simada H. Effects of TYB-2285 on accumulation of eosinophils into the airway induced by antigen exposure in actively sensitized Brown Norway (BN) rats. General Pharmacol 1996; Abstract.
13. 13. Abraham W M, Delehunt J C, Yerger L, Marchette B. Characterization of a late phase pulmonary response following antigen challenge in allergic sheep. Am Rev Respir Dis 1983; 128: 839-844.
14. 14. Lansing M W, Ahmed A, Cortes A, Sielczak M W, Wanner A, Abraham W M. Oxygen radicals contribute to antigen-induced airway hyperresponsiveness in conscious sheep. Am Rev Respir Dis 1993; 147: 321-326.
15. 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest 1994; 93: 776-787.
16. 16. Soler M, Sielczak M, Abraham W M. Separation of late bronchial responses from airway hyperresponsiveness in allergic sheep. J Appl Physiol 1991; 70: 617-623.
17. 3-mediated mast cell degranulation. J Appl Physiol 1994; 76: 893-901.
18. 18. Tomioka K, Jackowski J T, Abraham W M. Characterization of sulfidopeptide leukotriene responses in sheep tracheal smooth muscle in vitro. Can J Physiol Pharmacol 1991; 69: 805-811.
19. 4 in bronchoalveolar lavage fluid during biphasic allergic bronchoconstriction in sheep. Am Rev Respir Dis 1989; 139: 725-731.
20. 4 excretion during antigen-induced bronchoconstriction in allergic sheep. J Appl Physiol 1990; 68: 1321-1327.
21. 21. Abraham W M, Burch R M, Farmer S G, Sielczak M W, Ahmed A, Cortes A. A bradykinin antagonist modifies allergen-induced mediator release and late bronchial responses in sheep. Am Rev Respir Dis 1991; 143: 787-796.
22. 22. Diaz P, Gonzalez M C, Galleguillos F R, Ancic P, Cromwell O, Shepherd D, Durham S R, Gleich G J, Kay A B. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late phase asthmatic reactions. Am Rev Respir Dis 1989; 139: 1383-1389.
23. 23. de Monchy J G R, Kauffman H F, Venge P, Koeter G H, Jansen H M, Sluiter H J, de Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373-376.
24. 24. Abraham W M. The interaction among granulocyte lipid mediators and the generation of oxygen radicals in antigen-induced airway hyperresponsiveness. In: Dahlen S E, Hedqvist P, Samuelsson B, Taylor W A, Fritsch J, eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York: Raven Press, 1994: 131-140.
25. 25. Stevens W H M, Inman M D, Wattie J, O'Byrne P M. Allergen-induced oxygen radical release from bronchoalveolar lavage cells and airway hyperresponsiveness in dogs. Am J Respir Crit Care Med 1995; 151: 1526-1531.
26. 26. Ikuta N, Sugiyama S, Takagi K, Satake T, Ozawa T. Implication of oxygen radicals on airway hyperresponsiveness after ovalbumin challenge in guinea-pigs. Am Rev Respir Dis 1992; 145: 561-565.
27. 27. Pretolani M, Ruffié C, Lapa e Silva J-R, Joseph D, Lobb R R, Vargaftig B B. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in the guinea pig airways. J Exp Med 1994; 180: 795-805.
28. 28. Elices M J, Osborn L, Takada Y Crouse C, Luhowskyj S, Hemler M E, Lobb R R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990; 60: 577-584.
29. 29. Weller P F, Rand T H, Goelz S E, Chi-Rosso G, Lobb R J. Human eosinophil adherence to vascular endothelium mediated by binding to VCAM-1 and ELAM-1. Proc Natl Acad Sci USA 1991; 88: 7430-7433.
30. 30. Lobb R R, Hemler M E. The pathophysiologic role of α4 integrins in vivo. J Clin Invest 1994; 94: 1722-1728.
31. 31. Rabb H A, Olivenstein R, Issekutz T B, Renzi P M, Martin J G, Pantano R, Seguin S. The role of the leukocyte adhesion molecules VLA-4, LFA-1, and Mac-1 in allergic airway responses in the rat. Am J Respir Crit Care Med 1994; 149: 1186-1191.
32. 32. Ra C, Yasuda M, Yagita H, Okumura K. Fibronectin receptor integrins are involved in mast cell activation. J Allergy Clin Immunol 1994; 94 (Suppl.): 625-628.